Does Video-Assisted Thoracoscopic Surgery with Bullectomy and Partial Pleurectomy for Primary Spontaneous Pneumothorax Impair Health-Related Quality of Life and Pulmonary Function?
VATS
pulmonary function
quality of life
Journal
Healthcare (Basel, Switzerland)
ISSN: 2227-9032
Titre abrégé: Healthcare (Basel)
Pays: Switzerland
ID NLM: 101666525
Informations de publication
Date de publication:
29 Oct 2021
29 Oct 2021
Historique:
received:
16
09
2021
revised:
21
10
2021
accepted:
27
10
2021
entrez:
27
11
2021
pubmed:
28
11
2021
medline:
28
11
2021
Statut:
epublish
Résumé
Video-assisted thoracoscopic surgery (VATS) with partial pleurectomy is an established treatment for primary spontaneous pneumothorax (PSP). However, postoperative pulmonary function and health-related quality of life (HR-QoL) after VATS-bullectomy with partial pleurectomy (VBPP) have not been elucidated. Eligible patients were assessed for HR-QoL using the Short-Form 36 (SF-36) health survey. Pulmonary function (PF) was evaluated by spirometry. We compared the results of the VBPP cohort with the German national norms, and with a similar cohort of patients successfully treated by chest tube (CT) only. A total of 25 VBPP patients completed the SF-36 health survey, of whom 15 presented for PF assessment. Between the VBPP and CT groups, the mean forced vital capacity (FVC), forced expiratory volume in one second (FEV1), and FEV1/FVC ratio were not statistically significantly different. However, in both groups, FVC, FEV1, and FEV1/FVC were above the lower limit of normal (LLN), suggesting no restrictive or obstructive patterns. Compared with the sex- and age-matched normal German population, patients who underwent VBPP displayed a similar physical component summary score and a significantly decreased mental component summary score. Interestingly, comparison of the SF-36 domains between the VBPP and CT groups showed no statistical difference. VBPP is a suitable surgical treatment for PSP, with no apparent adverse impacts on pulmonary or physical function. However, psychological distress and measures to counteract its impact should be considered.
Sections du résumé
BACKGROUND
BACKGROUND
Video-assisted thoracoscopic surgery (VATS) with partial pleurectomy is an established treatment for primary spontaneous pneumothorax (PSP). However, postoperative pulmonary function and health-related quality of life (HR-QoL) after VATS-bullectomy with partial pleurectomy (VBPP) have not been elucidated.
METHODS
METHODS
Eligible patients were assessed for HR-QoL using the Short-Form 36 (SF-36) health survey. Pulmonary function (PF) was evaluated by spirometry. We compared the results of the VBPP cohort with the German national norms, and with a similar cohort of patients successfully treated by chest tube (CT) only.
RESULTS
RESULTS
A total of 25 VBPP patients completed the SF-36 health survey, of whom 15 presented for PF assessment. Between the VBPP and CT groups, the mean forced vital capacity (FVC), forced expiratory volume in one second (FEV1), and FEV1/FVC ratio were not statistically significantly different. However, in both groups, FVC, FEV1, and FEV1/FVC were above the lower limit of normal (LLN), suggesting no restrictive or obstructive patterns. Compared with the sex- and age-matched normal German population, patients who underwent VBPP displayed a similar physical component summary score and a significantly decreased mental component summary score. Interestingly, comparison of the SF-36 domains between the VBPP and CT groups showed no statistical difference.
CONCLUSION
CONCLUSIONS
VBPP is a suitable surgical treatment for PSP, with no apparent adverse impacts on pulmonary or physical function. However, psychological distress and measures to counteract its impact should be considered.
Identifiants
pubmed: 34828509
pii: healthcare9111463
doi: 10.3390/healthcare9111463
pmc: PMC8622740
pii:
doi:
Types de publication
Journal Article
Langues
eng
Références
Surg Today. 2009;39(7):553-7
pubmed: 19562440
Respiration. 2019;97(4):370-402
pubmed: 30041191
Ann Surg Oncol. 2020 Apr;27(4):1259-1271
pubmed: 31788755
Eur Respir J. 2015 Aug;46(2):321-35
pubmed: 26113675
World J Surg. 2018 Oct;42(10):3256-3262
pubmed: 29717345
Eur J Cardiothorac Surg. 2011 Jul;40(1):120-3
pubmed: 21115258
N Engl J Med. 2000 Mar 23;342(12):868-74
pubmed: 10727592
Ann Thorac Surg. 2015 Jan;99(1):210-7
pubmed: 25440275
J Trauma. 2005 Dec;59(6):1365-71; discussion 1371-4
pubmed: 16394910
Trials. 2015 Nov 30;16:540
pubmed: 26620271
Med Care. 1992 Jun;30(6):473-83
pubmed: 1593914
Eur Arch Otorhinolaryngol. 2019 Sep;276(9):2441-2447
pubmed: 31177326
Eur J Cardiothorac Surg. 2016 Apr;49(4):1084-90
pubmed: 26374869
Med Care. 1988 Jul;26(7):724-35
pubmed: 3393032
Lancet Oncol. 2016 Aug;17(8):e316-e317
pubmed: 27511153
Thorax. 2010 Aug;65 Suppl 2:ii18-31
pubmed: 20696690
World J Surg. 2019 Aug;43(8):2099-2105
pubmed: 30972431
Surg Today. 2007;37(9):745-9
pubmed: 17713727
Interact Cardiovasc Thorac Surg. 2008 Feb;7(1):45-9
pubmed: 17704125
Am Fam Physician. 2014 Mar 1;89(5):359-66
pubmed: 24695507
Interact Cardiovasc Thorac Surg. 2019 Feb 1;28(2):199-205
pubmed: 30085061
Curr Opin Pulm Med. 2003 Jul;9(4):272-5
pubmed: 12806239
Transplant Proc. 2019 Oct;51(8):2761-2765
pubmed: 31493914